The U.S. Food and Drug Administration (FDA) has announced a roundtable discussion with small electronic nicotine delivery system (ENDS) manufacturers to gather feedback on the premarket tobacco product application (PMTA) process. The meeting will take place on February 10, 2026, from 9:00 a.m. to 5:00 p.m. ET, and is intended for manufacturers with fewer than 350 employees who have previously submitted an ENDS PMTA, including those with applications currently under review.

Participation as a panelist will be limited to 30 representatives, with registration open until January 27, 2026, subject to availability. The roundtable will cover key PMTA components such as product characterization, manufacturing controls, pharmacological and toxicological profiles, and studies demonstrating potential adult benefit. The meeting will be open for public viewing online, recorded, and captioned. FDA has also opened a public docket for comments related to the discussion, with submissions due by February 3, 2026, for roundtable consideration, and by March 12, 2026, for general comment.

Consumer News Region
Consumer News Tags
USA; Premarket tobacco product application (PMTA); Toxicological profiles